Welcome Guest user | Log in | Athens Login | Shibboleth Login | Register
Resources
Register
For Authors
For Librarians
For Advertisers
Services
Subscriptions/Pricing
Reprints
Advertising
Press Releases/News
Help
Downloads/Links
2008/9 Catalogue
Library Recommendation
 

Summary
March 2006, Vol. 7, No. 2, Pages 247-253 , DOI 10.2217/14622416.7.2.247
(doi:10.2217/14622416.7.2.247)

Special Report
Clinical genomics data standards for pharmacogenetics and pharmacogenomics
Amnon Shabo (Shvo)
IBM Research Lab in Haifa, Haifa University Campus, Mount Carmel, Haifa, 31905, Israel



This special report concerns a talk on data standards given at a workshop entitled ‘An International Perspective on Pharmacogenetics: The Intersections between Innovation, Regulation and Health Delivery’, which was held by the Organization for Economic Co-operation and Development (OECD) on October 17–19, 2005, in Rome, Italy. The worlds of healthcare and life sciences (HCLS) are extremely fragmented in terms of their underlying information technology, making it difficult to semantically exchange information between disparate entities. While we have reached the point where functional interoperability is ubiquitous, we are still far from achieving true semantic interoperability where a receiving system can use incoming data as though it was created internally. The critical enablers of semantic interoperability are information standards dedicated to HCLS data, spanning all the way from biological research data to clinical research and clinical trials, and finally to healthcare clinical data. The challenge lies in integrating various data standards based on predetermined goals, thereby improving the quality of care provided to patients.

Full Text PDF (297 KB) PDF Plus (268 KB)
 

Prev. Article | Next Article
View/Print PDF (297 KB)
View PDF Plus (268 KB)
Add to favorites
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Author:
Amnon Shabo (Shvo)
Keywords:
clinical genomics
healthcare
information standards
life sciences
pharmacogenetics
pharmacogenomics
personalized medicine